Nishtha Pandit
InvestorCreative Associate at Spring Marketing Capital · Interim Chairperson of the Board at PureTech Health
Find your path to Nishtha
48 people in our graph share verified history with Nishtha — schools, employers, funds. One of them is your warm intro.
About
Nishtha Pandit is Interim Chairperson of the Board at PureTech Health plc, where she also chairs the Audit Committee and serves on the Transaction Committee. She is CFO of the U.S. business at Teva Pharmaceuticals, overseeing a portfolio of more than 1,000 products across specialty, biosimilars, and generics generating over $8 billion in annual revenue, with responsibilities spanning investor relations, capital markets strategy, and debt refinancing. Earlier in her career, she spent 22 years at Merck, including roles as CFO of US Oncology and leader of Portfolio Strategy, Operations, and Business Analytics, and later served as SVP of Global Finance at EQRx.
Colleagues at Spring Marketing Capital
Frequently asked questions
- Who is Nishtha Pandit?
- Nishtha Pandit is Interim Chairperson of the Board at PureTech Health plc, where she also chairs the Audit Committee and serves on the Transaction Committee. She is CFO of the U.S. business at Teva Pharmaceuticals, overseeing a portfolio of more than 1,000 products across specialty, biosimilars, and generics generating over $8 billion in annual revenue, with responsibilities spanning investor relations, capital markets strategy, and debt refinancing. Earlier in her career, she spent 22 years at Merck, including roles as CFO of US Oncology and leader of Portfolio Strategy, Operations, and Business Analytics, and later served as SVP of Global Finance at EQRx.
- Where does Nishtha Pandit work?
- Nishtha Pandit is Creative Associate at Spring Marketing Capital.









